tiprankstipranks
Decibel Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyDecibel Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
9M ago
Regeneron to acquire Decibel Therapeutics for $4.00 per share plus CVR
PremiumThe Fly
Regeneron to acquire Decibel Therapeutics for $4.00 per share plus CVR
9M ago
Regeneron to acquire Decibel Therapeutics for $4.00 per share plus CVR
PremiumThe Fly
Regeneron to acquire Decibel Therapeutics for $4.00 per share plus CVR
9M ago
Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
PremiumPress ReleasesDecibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
12M ago
Decibel Therapeutics receives European ODD for DB-OTO
PremiumThe Fly
Decibel Therapeutics receives European ODD for DB-OTO
1y ago
Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO
PremiumPress Releases
Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO
1y ago
Decibel downgraded to Market Perform from Outperform at SVB Securities
PremiumThe FlyDecibel downgraded to Market Perform from Outperform at SVB Securities
1y ago
Decibel downgraded to Market Perform from Outperform at SVB Securities
PremiumThe Fly
Decibel downgraded to Market Perform from Outperform at SVB Securities
1y ago
Decibel Therapeutics reports Q4 cash position $104.6M vs $162.3M last year
PremiumThe Fly
Decibel Therapeutics reports Q4 cash position $104.6M vs $162.3M last year
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100